Key result
Time in range >70% linked to ~17-point higher 12-month patency after femoropopliteal intervention.
Why the study?
The correlation between glucose time in range (TIR) and primary patency after endovascular therapy for diabetic femoropopliteal artery occlusion needed assessment.
Does a glycemic time in range (TIR) > 70% improve 12-month primary patency in patients with type 2 diabetes and femoropopliteal artery occlusion undergoing endovascular therapy?
Cohort (n=162)
No
Does a glycemic time in range (TIR) > 70% improve 12-month primary patency in patients with type 2 diabetes and femoropopliteal artery occlusion undergoing endovascular therapy?
Answers are grounded in this paper and cite their sources.
Achieving a glycemic time in range (TIR) > 70% is independently associated with higher 12-month primary patency and lower rates of restenosis and target lesion revascularization in patients with diabetic femoropopliteal artery occlusion undergoing endovascular therapy.
This study aims to assess the correlation between time in range (TIR) and the primary outcome of diabetic femoropopliteal artery occlusion (DFO) after endovascular therapy. In this prospective cohort study, 162 patients with DFO were divided into two groups according to their seven-point glucose profiles within 7 days: those with a TIR below 70% (TBS) and those with a TIR above 70% (TAS). The clinical and follow-up data were analyzed. The TIR value in TBS was lower than that in TAS (58.84 ± 7.72% vs. 78.34 ± 6.13%) and duration above the range (34.79 ± 8.39% vs. 15.92 ± 5.89%; P < 0.001) were greater in TBS group. The primary patency rate in TBS group was lower than that in TAS group at 12-month (71.67% vs. 88.54%, P = 0.006). The restenosis (28.33% vs. 11.46%; P = 0.007) and clinical-driven target lesion revascularization (23.33% vs. 8.33%; P = 0.009) were greater in TBS group. Severe calcification (hazard ratio (HR): 4.08, 95% confidence interval (CI): 1.86–8.97; P < 0.001) and TIR (HR: 0.025, 95% CI: 0.001-0.70; P = 0.03) were confirmed to be independent risk factors for restenosis. Our results suggested that TIR > 70% was associated with greater primary patency after endovascular therapy, which might be a potential indicator of DFO revascularization.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) conducted a cohort in Diabetic femoropopliteal artery occlusion (DFO) (n=162). Time in range (TIR) > 70% (TAS) vs. Time in range (TIR) ≤ 70% (TBS) was evaluated on Primary patency at 12 months (freedom from occlusion/stenosis >50% of the target lesion) (p=0.006). Time in range >70% was associated with a higher 12-month primary patency rate compared to TIR ≤70% after endovascular therapy for diabetic femoropopliteal occlusion.
Synapse has enriched 10 related papers. Consider them for comparative context: